Device Trial Radar · NCT04315415
A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
Last checked: Nov 20, 2026Latest source record: Apr 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Jan 15, 2020
Primary completion
Feb 17, 2022
Study completion Apr 18, 2022
Sponsor
- Lead sponsor
- Sofregen Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 19, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary study goal is to evaluate the histological characteristic of Silk Voice to evaluate the potential for Silk Voice to deliver long-term results to patients.
Conditions
- Vocal Fold Palsy
- Vocal Cord Paralysis
- Vocal Cord Atrophy
Interventions
Silk VoiceDevice
Silk Voice comprised of silk protein and cross-linked hyaluronic acid (HA)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 6 month
- Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 12 month
- Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 24 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
DeNova Research
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.